Epizyme Reports Positive Data on Tazemetostat in Epithelioid Sarcoma from its Phase 2 Trial Cohort at ESMO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 22, 2018-- Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic...
Health News 2 me
healthnews2me.com
Tag: ESMO